Literature DB >> 3142607

Severe reaction to diphosphonate.

R E Gray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3142607      PMCID： PMC1834772          DOI： 10.1136/bmj.297.6655.1042

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

Authors:  A J Yates; R C Percival; R E Gray; R M Atkins; G H Urwin; N A Hamdy; C J Preston; M N Beneton; R G Russell; J A Kanis
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

2.  Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

Authors:  H I Harinck; S E Papapoulos; H J Blanksma; A J Moolenaar; P Vermeij; O L Bijvoet
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

3.  Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.

Authors:  C A Mautalen; C A Casco; D Gonzalez; G R Ghiringhelli; C Massironi; G A Fromm; L Plantalech
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-17

4.  Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy.

Authors:  D Thiébaud; L Portmann; P Jaeger; A F Jacquet; P Burckhardt
Journal:  Bone       Date:  1986       Impact factor: 4.398

5.  Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.

Authors:  M C Chapuy; S A Charhon; P J Meunier
Journal:  Metab Bone Dis Relat Res       Date:  1983

6.  Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.

Authors:  R S Witte; J Koeller; T E Davis; A B Benson; B G Durie; A Lipton; J L Stock; D L Citrin; T P Jacobs
Journal:  Arch Intern Med       Date:  1987-05

Review 7.  Long-term follow-up observations on treatment in Paget's disease of bone.

Authors:  J A Kanis; R E Gray
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

8.  The acute-phase response after bisphosphonate administration.

Authors:  S Adami; A K Bhalla; R Dorizzi; F Montesanti; S Rosini; G Salvagno; V Lo Cascio
Journal:  Calcif Tissue Int       Date:  1987-12       Impact factor: 4.333
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.